SKYE BIOSCIENCE INC. - COMMON STOCK

Skye Concentrates Strategy and Clinical Development Focus on Nimacimab Metabolic Program

10 يونيو 2024 07:00:00 بحسب Nasdaq GlobeNewswire

Skye Bioscience to Present at Jefferies Global Healthcare Conference

03 يونيو 2024 07:00:00 بحسب Nasdaq GlobeNewswire

Skye Bioscience Highlights Novel Synthetic Cannabinoid-based Library Capable of Modulating the Endocannabinoid System to Treat Ocular Diseases at ARVO 2024 Annual Meeting

10 مايو 2024 07:00:00 بحسب Nasdaq GlobeNewswire

Skye Bioscience to Present Two Posters at Association for Research in Vision and Ophthalmology (ARVO) 2024 Annual Meeting

30 أبريل 2024 07:00:00 بحسب Nasdaq GlobeNewswire

Skye Bioscience to Present at Upcoming Investment Conferences

23 أبريل 2024 07:00:00 بحسب Nasdaq GlobeNewswire